![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:DOT1L-GNA11 (FusionGDB2 ID:HG84444TG2767) |
Fusion Gene Summary for DOT1L-GNA11 |
![]() |
Fusion gene information | Fusion gene name: DOT1L-GNA11 | Fusion gene ID: hg84444tg2767 | Hgene | Tgene | Gene symbol | DOT1L | GNA11 | Gene ID | 84444 | 2767 |
Gene name | DOT1 like histone lysine methyltransferase | G protein subunit alpha 11 | |
Synonyms | DOT1|KMT4 | FBH|FBH2|FHH2|GNA-11|HHC2|HYPOC2 | |
Cytomap | ('DOT1L')('GNA11') 19p13.3 | 19p13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | histone-lysine N-methyltransferase, H3 lysine-79 specificDOT1 like histone H3K79 methyltransferaseDOT1-like histone methyltransferaseDOT1-like proteinDOT1-like, histone H3 methyltransferaseH3-K79-HMTasehistone H3-K79 methyltransferasehistone methyl | guanine nucleotide-binding protein subunit alpha-11g alpha-11guanine nucleotide binding protein (G protein), alpha 11 (Gq class)guanine nucleotide-binding protein G(y) subunit alpha | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000398665, ENST00000608122, | ||
Fusion gene scores | * DoF score | 22 X 15 X 12=3960 | 5 X 7 X 5=175 |
# samples | 29 | 7 | |
** MAII score | log2(29/3960*10)=-3.77137562495204 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/175*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: DOT1L [Title/Abstract] AND GNA11 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | DOT1L(2227126)-GNA11(3118922), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | DOT1L-GNA11 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. DOT1L-GNA11 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. DOT1L-GNA11 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. DOT1L-GNA11 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. DOT1L-GNA11 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. DOT1L-GNA11 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | DOT1L | GO:0008284 | positive regulation of cell proliferation | 15851025 |
Hgene | DOT1L | GO:0034729 | histone H3-K79 methylation | 15851025 |
Hgene | DOT1L | GO:0045944 | positive regulation of transcription by RNA polymerase II | 15851025 |
Hgene | DOT1L | GO:0046425 | regulation of JAK-STAT cascade | 22002246 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LIHC | TCGA-EP-A2KA-01A | DOT1L | chr19 | 2227126 | + | GNA11 | chr19 | 3118922 | + |
Top |
Fusion Gene ORF analysis for DOT1L-GNA11 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000398665 | ENST00000586180 | DOT1L | chr19 | 2227126 | + | GNA11 | chr19 | 3118922 | + |
Frame-shift | ENST00000398665 | ENST00000078429 | DOT1L | chr19 | 2227126 | + | GNA11 | chr19 | 3118922 | + |
intron-3CDS | ENST00000608122 | ENST00000078429 | DOT1L | chr19 | 2227126 | + | GNA11 | chr19 | 3118922 | + |
intron-3UTR | ENST00000608122 | ENST00000586180 | DOT1L | chr19 | 2227126 | + | GNA11 | chr19 | 3118922 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for DOT1L-GNA11 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
DOT1L | chr19 | 2227126 | + | GNA11 | chr19 | 3118921 | + | 0.00023497 | 0.999765 |
DOT1L | chr19 | 2227126 | + | GNA11 | chr19 | 3118921 | + | 0.00023497 | 0.999765 |
![]() |
![]() |
Top |
Fusion Protein Features for DOT1L-GNA11 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:2227126/:3118922) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for DOT1L-GNA11 |
![]() |
Top |
Fusion Gene PPI Analysis for DOT1L-GNA11 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DOT1L-GNA11 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for DOT1L-GNA11 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | DOT1L | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Tgene | C0220633 | Uveal melanoma | 5 | CGI;CTD_human;ORPHANET | |
Tgene | C1840347 | HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II (disorder) | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C3809243 | HYPOCALCEMIA, AUTOSOMAL DOMINANT 2 | 3 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0346373 | Malignant melanoma of iris | 2 | ORPHANET | |
Tgene | C0346388 | Malignant melanoma of choroid | 2 | ORPHANET | |
Tgene | C0018798 | Congenital Heart Defects | 1 | CTD_human | |
Tgene | C0025202 | melanoma | 1 | CGI;CTD_human | |
Tgene | C0235753 | Congenital hemangioma | 1 | GENOMICS_ENGLAND | |
Tgene | C1274879 | Port-wine stain with oculocutaneous melanosis | 1 | GENOMICS_ENGLAND | |
Tgene | C3715128 | HYPOCALCEMIA, AUTOSOMAL DOMINANT 1 | 1 | ORPHANET | |
Tgene | C3838883 | Phakomatosis cesioflammea | 1 | ORPHANET | |
Tgene | C3839296 | Phakomatosis cesiomarmorata | 1 | ORPHANET | |
Tgene | C4048195 | Autosomal dominant hypocalcemia | 1 | ORPHANET | |
Tgene | C4552089 | HYPOCALCEMIA, AUTOSOMAL DOMINANT 1, WITH BARTTER SYNDROME | 1 | ORPHANET |